drugset / Trial / NCT00036777
UCN-01 and Carboplatin in Treating Patients With Advanced Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
Phase I trial to study the effectiveness of combining UCN-01 with carboplatin in treating patients who have advanced solid tumors. UCN-01 may stop the growth of tumor cells by blocking the enzymes necessary for tumor cell growth. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining UCN-01 with carboplatin may kill more tumor cells.
Timeline
- Start
- 2002-03
- Primary completion
- 2004-10
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carboplatin | Small molecule | — | Intravenous |
| Subject | UCN-01 | Small molecule | — | Intravenous |